CorpDev.Org
Deal Intelligence Platform & Services for Global M&A / PE
Big Deal
Netflix Re-Engages in Strategic M&A, Acquiring Ben Affleck’s AI Firm InterPositive
By A Wall Street Journal Reporter | Published March 5, 2026 Netflix has quietly re-entered the strategic acquisition arena, announcing the purchase of InterPositive, an artificial-intelligence filmmaking technology company founded by Academy...
Pentagon Anchors $150M Maritime Tech VC Fund, Signaling Intensified Focus on Dual-Use National Security Investments
The Department of Defense (DoD) is significantly deepening its engagement with the U.S. venture capital ecosystem, marking a renewed push to shepherd capital toward technologies deemed critical for national security. The latest data points toward a...
TPG Explores $7.6 Billion Exit for Asia OneHealthcare, Signaling Maturity in Southeast Asian Healthcare Buyouts
Private equity giant TPG is weighing strategic options for its Southeast Asian healthcare portfolio company, Asia OneHealthcare, including a potential sale or an initial public offering (IPO) that could fetch an enterprise valuation near 30 billion...
Akio Toyoda Secures Legacy in ¥6.7 Trillion Buyout, Reshaping Toyota Group Structure
In a landmark corporate maneuver testing the boundaries of Japan's evolving corporate governance landscape, the Toyota Group, led by Chairman Akio Toyoda, has successfully orchestrated the privatization of its founding entity, Toyota Industries...
PE Still Vital to CalPERS’ Strategy Under TPA: CEO
California Public Employees' Retirement System (CalPERS) continues to prioritize private equity as a core component of its investment portfolio, even after transitioning to a third-party administrator (TPA) model, according to its CEO. This stance...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Novo’s $2.1B Vivtex Deal Boosts Obesity Drug Pipeline
Novo Nordisk entered a partnership worth up to $2.1 billion with Vivtex Corp. to develop next-generation oral medicines for obesity and diabetes, leveraging Vivtex's drug delivery technology to expand beyond injectable GLP-1 therapies like Wegovy. ...
GSK Secures Potential ‘Multi-Blockbuster’ Drug in $950 Million 35Pharma Acquisition
null GlaxoSmithKline announced today that it has acquired 35Pharma Inc., a Montreal-based clinical-stage biopharmaceutical company, for $950 million in cash. The deal grants GSK access to HS235, an investigational activin signaling inhibitor...
Danaher’s $9.9 Billion Masimo Acquisition Signals Consolidation in Patient Monitoring Technology
null Danaher Corporation has agreed to acquire Masimo Corporation for $180 per share in an all-cash transaction valued at approximately $9.9 billion, marking a significant consolidation move in the medical device sector focused on acute care...
Humana Nears $1 Billion Acquisition of MaxHealth, Targets Florida Primary Care Expansion
Humana Inc. is in advanced talks to acquire Sarasota, Florida-based MaxHealth, a primary care network, in a deal approaching $1 billion, according to Bloomberg reports. The transaction underscores Humana's strategy to deepen vertical integration...
Eli Lilly Bets $2.4 Billion on Orna Therapeutics to Advance In Vivo Cell Therapies
Eli Lilly agreed to acquire Orna Therapeutics for up to $2.4 billion in cash, securing access to proprietary circular RNA technology for in vivo cell engineering in autoimmune diseases and oncology. Set and exceed synergy goals with benchmarks...
